Delivery Order SPE2DB20D3103-SPE2DB23FN5X7
- Not listed
- This federal contract award is for the delivery of EXJADE 250 MG TABLET 30S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,034.60 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 13, 2023, with a completion date of August 3, 2023. The contract is a delivery order placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,206.51 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of EXJADE 500 MG TABLET 30S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as Amerisourcebergen Drug Corp's primary vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,027.08 for Exjade 500 mg tablets (30-count units) on August 5, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price contract, which is not set-aside, represents a routine pharmaceutical supply requirement fulfilled by the prime contractor at its Conshohocken, Pennsylvania facility. The award is issued as a child contract under AmerisourceBergen's larger Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EXJADE 250 MG TABLET 30S. The contract has a potential value of $3,418.22 and a completion date of January 25, 2024. The contract supports the provision of pharmaceuticals and medical supplies to military treatment programs and facilities. No set-aside designation was used for this award....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,500.61 firm fixed-price delivery order is for the supply of JADENU 360 MG TABLET 30S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive...
- This federal contract award, valued at $29,517.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product Jadenu 360 mg Tablet 30s, with a completion date of April 28, 2025. The contract is a firm fixed-price arrangement and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award, SPE2DX15D1053|SPE2DX24F6PLM, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,456.77 firm fixed-price delivery order is for the supply of JADENU 360 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award, valued at $15,789.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,092,751 units of the medication Deferasirox 500 mg tablets for suspension, with a performance period ending on May 1, 2025. The contract is not set-aside and was awarded on a firm-fixed-price basis. Amerisourcebergen Drug Corp, the prime...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the supply of the pharmaceutical product JADENU 360 MG TABLET 30S. The $23,699.34 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $21,354.75 firm fixed-price delivery order is for the supply of JADENU 360 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of prescription medications,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN5X7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,034.60 firm-fixed-price delivery order is for the supply of Exjade 250 mg tablets. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Through its extensive distribution capabilities, Amerisourcebergen has established itself as a key vendor for federal healthcare programs, particularly within the Department of Defense (DoD) and Department of Veterans Affairs (VA) medical systems. The contract award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 6/1/23 |